AI & RoboticsNews

AI-formulated medicine to be tested on humans for the first time

A drug designed entirely by artificial intelligence is about to enter clinical human trials for the first time. The drug, which is intended to treat obsessive-compulsive disorder, was discovered using AI systems from Oxford-based biotech company Exscientia. While it would usually take around four and a half years to get a drug to this stage of development, Exscientia says that by using the AI…
Read more
AI & RoboticsNews

With Google’s Meena, are AI assistants about to get a lot smarter?

Last year, we got to see coherent, multi-paragraph text generated by OpenAI’s GPT-2 model. This week, a new paper from Google AI showed that a chatbot based on a gigantic neural network and huge amounts of data can hold coherent conversations, maintaining context over multiple turns and conversing on just about any topic. The chatbot is called Meena, and it’s even able to invent jokes (see…
Read more
AI & RoboticsNews

DeepMind’s MEMO AI solves novel reasoning tasks with less compute

Can AI capture the essence of reasoning — that is, the appreciation of distant relationships among elements distributed across multiple facts or memories? Alphabet subsidiary DeepMind sought to find out in a study published on the preprint server Arxiv.org, which proposes an architecture — MEMO — with the capacity to reason over long distances. They say that its two novel components — the…
Read more
AI & RoboticsNews

Amazon details AI that answers questions more reliably

Might natural language models improve in their ability to answer questions on the fly? That’s what a team of Amazon researchers set out to answer in a study scheduled to be presented at the 2020 Association for the Advancement of Artificial Intelligence in New York. They posit a method for adapting models based on Google’s Transformer architecture — which is particularly good at learning…
Read more